Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
New clinical trial to test cancer drug in patients with advanced solid tumors

New clinical trial to test cancer drug in patients with advanced solid tumors

Research suggests novel approach to treating deadly pancreatic cancer

Research suggests novel approach to treating deadly pancreatic cancer

New study identifies gene critical to pancreatic cancer cell growth

New study identifies gene critical to pancreatic cancer cell growth

Study reveals strong prognostic indicators of survival in resected pancreatic cancer

Study reveals strong prognostic indicators of survival in resected pancreatic cancer

Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy

Moffitt Cancer Center and Cvergenx form research partnership to revolutionize radiation therapy

Scope maker Olympus hit with $6.6 million verdict in superbug outbreak case

Scope maker Olympus hit with $6.6 million verdict in superbug outbreak case

Two cell types partner to protect pancreatic tumors from immune attack

Two cell types partner to protect pancreatic tumors from immune attack

UK behind other European countries in cancer care, report says

UK behind other European countries in cancer care, report says

Newly identified biomarker panel could pave way to earlier detection of pancreatic cancer

Newly identified biomarker panel could pave way to earlier detection of pancreatic cancer

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Safe under the ACA, patients with preexisting conditions now fear bias

Safe under the ACA, patients with preexisting conditions now fear bias

Researchers suggest new strategy to identify germline mutations in men with prostate cancer

Researchers suggest new strategy to identify germline mutations in men with prostate cancer

Two-test combination accurately identifies benign pancreatic lesions

Two-test combination accurately identifies benign pancreatic lesions

Could a blood test predict how cancer spreads in children?

Could a blood test predict how cancer spreads in children?

Blocking newly discovered cellular pathway could help control tumor growth

Blocking newly discovered cellular pathway could help control tumor growth

Widow unleashes court fight against scope maker Olympus over superbug outbreak

Widow unleashes court fight against scope maker Olympus over superbug outbreak

Antibody-based theranostic agent shows promise for identifying and treating pancreatic tumors

Antibody-based theranostic agent shows promise for identifying and treating pancreatic tumors

'Mismatch repair' genetic defects drive cancer patient's response to immunotherapy drugs

'Mismatch repair' genetic defects drive cancer patient's response to immunotherapy drugs

Genetic manipulation of exosomes may offer new therapeutic approach to treating pancreatic cancer

Genetic manipulation of exosomes may offer new therapeutic approach to treating pancreatic cancer

Positive results for AstraZeneca’s PARP inhibitor Lynparza in advanced breast cancer

Positive results for AstraZeneca’s PARP inhibitor Lynparza in advanced breast cancer